– Bloomberg
Gilead Sciences Bets $400M On Inflammatory Diseases Focused UK Based Firm
Gilead Sciences Inc (NASDAQ:GILD) has agreed to acquire MiroBio, a privately-held U.K.-based biotechnology company focused on restoring immune balance with agonists…